| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Viking Therapeutics, Inc. (VKTX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 28 sells. VKTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.51M | $81.11M | - | |
| COO | 410.8K | $13.30M | - | |
| CFO | 215.6K | $6.98M | - | |
| Dir | 148.0K | $4.79M | - | |
| Dir | 51.1K | $1.65M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2024 | Lian Brian52 | President &CEO | Sale+OE | 216,130 | $70.83 | $15,308,552.90 | -3.0% | -41.1% | -64.0% | |
| Aug 21, 2024 | Lian Brian52 | President &CEO | Sale+OE | 1,000 | $69.90 | $69,900.00 | - | -20.5% | -60.4% | |
| Aug 21, 2024 | Singleton J Matthew75 | Director | Sale+OE | 5,700 | $69.72 | $397,430.22 | -37.5% | -20.5% | -60.4% | |
| Aug 19, 2024 | Singleton J Matthew75 | Director | Sale+OE | 16,000 | $62.22 | $995,453.24 | -14.8% | -26.3% | -63.4% | |
| Aug 19, 2024 | Lian Brian52 | President &CEO | Sale+OE | 112,870 | $65.80 | $7,426,507.68 | -1.6% | -26.3% | -63.4% | |
| Aug 14, 2024 | Singleton J Matthew75 | Director | Sale+OE | 20,786 | $57.53 | $1,195,736.21 | -52.0% | +4.1% | -30.9% | |
| Jul 30, 2024 | Zante Greg54 | Chief Financial Officer | Sell | 16,136 | $57.15 | $922,212.06 | -2.8% | +31.8% | -40.4% | |
| Jul 30, 2024 | Lian Brian52 | President &CEO | Sell | 115,859 | $57.58 | $6,670,604.02 | -1.6% | +31.8% | -40.4% | |
| Jul 30, 2024 | Mancini Marianna55 | Chief Operating Officer | Sell | 18,026 | $57.13 | $1,029,911.96 | -2.4% | +31.8% | -40.4% | |
| May 3, 2024 | Zante Greg54 | Chief Financial Officer | Sale+OE | 66,756 | $74.69 | $4,986,007.97 | -7.9% | -29.0% | -61.9% |